{"id":"W2566019957","doi":"10.1182/blood.v104.11.4225.4225","title":"CERA (Continuous Erythropoietin Receptor Activator): Dose-Response Trial of Subcutaneous (SC) Administration Once Every 3 Weeks (Q3W) to Patients with Aggressive Non-Hodgkin’s Lymphoma and Anemia Receiving Chemotherapy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Anemia; Internal medicine; Gastroenterology; Chemotherapy; Chemotherapy regimen; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001301213,0.0008842954,0.001511801,0.0003426361,0.0002945685,0.000608981,0.0006124629,0.0008309995,0.002503588],"category_scores_gemma":[0.0007406637,0.0003972307,0.000899767,0.0003507603,0.0008092503,0.0004710998,0.0002873114,0.002370746,0.0005886413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004883643,"about_ca_system_score_gemma":0.0009718928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001106336,"about_ca_topic_score_gemma":0.002257037,"domain_scores_codex":[0.9996724,0.0001862117,0.00001268536,0.00004358694,0.00002182874,0.00006333116],"domain_scores_gemma":[0.9992734,0.0001642111,0.0001212525,0.00005339825,0.00003208841,0.0003557625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9135148,0.02811189,0.002087646,0.0002637674,0.0004569185,0.00009216844,0.0001310285,0.001075887,0.01559604,0.0001702797,0.001070707,0.0374288],"study_design_scores_gemma":[0.74168,0.2504685,0.004793173,0.00001202835,0.000138701,0.00005873502,0.0000234087,0.0009656894,0.001212848,0.0000821788,0.0005542212,0.00001052694],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962581,0.0007475257,0.000346219,0.0001754174,0.00009417002,0.001210009,0.0002520435,0.0000580891,0.0008583769],"genre_scores_gemma":[0.9954854,0.0005693926,0.0007645081,0.0002911828,0.0001057451,0.000951097,0.0005201437,0.00001155733,0.001300971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002503588,"threshold_uncertainty_score":0.008375287,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007099199901736731,"score_gpt":0.2591046772744383,"score_spread":0.2520054773727016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}